SlideShare a Scribd company logo
1 of 21
DIABETIC
RETINOPATHY
DONE BY ARANI DUSHYANTH
GROUP:303
DIABETES MELLITUS
• Diabetes Mellitus is a group of diseases characterized by high
blood glucose levels. Diabetes results from defects in the
body’s ability to produce and/or use insulin.
• Type 1 diabetes is usually diagnosed in children and young
adults, and was previously known as juvenile diabetes. In type 1
diabetes, the body does not produce insulin. 5% of people with
diabetes have this form of the disease.
• In Type 2 diabetes, either the body does not produce enough
insulin or the cells ignore the insulin. This is the most common
form of diabetes.
DIABETIC RETINOPATHY (DR)
• Diabetic Retinopathy (DR)
Definition:
• Progressive dysfunction of the retinal blood vessels caused by
chronic hyperglycemia.
• DR can be a complication of diabetes type 1 or diabetes type 2.
• Initially, DR is asymptomatic, if not treated though it can cause
low vision and blindness.
RETINA
The retina is a multilayered, light sensitive neural tissue
lining the inner eye ball. Light is focused onto the retina
and then transmitted to the brain through the optic nerve.
The macula is a highly sensitive area in the center of the
retina, responsible for central vision. The macula is
needed for reading, recognizing faces and executing
other activities that require fine, sharp vision.
DIABETIC RETINOPATHY
EPIDEMIOLOGY
The total number of people with diabetes is projected to
rise from 285 million in 2010 to 439 million in 2030.
Diabetic retinopathy is responsible for 1.8 million of the
37 million cases of blindness throughout the world .
Diabetic retinopathy (DR) is the leading cause of blindness
in people of working age in industrialized countries.
SYMPTOMS
•It is asymptomatic In early stages
•As the disease progresses symptoms may
include
•Blurred vision
•Floaters
•Fluctuating vision
•Dark areas in the vision
•Poor night vision
•Impaired color vision
•Partial or total loss of vision
RISK FACTORS
1.Duration of diabetes
2.Poor Blood Sugar control
3.Hypertension
4.Hyperlipidemia
5.Barriers to care
•Duration of diabetes is a major risk factor
associated with the development of diabetic
retinopathy
•The severity of hyperglycemia is the key
alterable risk factor associated with the
development of diabetic retinopathy
PATHOPHYSIOLOGY
Diabetic Retinopathy is a microvasculopathy that
causes:
1.Retinal capillary occlusion
2.Retinal capillary leakage
MICROVASCULAR OCCLUSION
•It is caused by
1.Thickening of capillary basement membranes
2.Abnormal proliferation of capillary endothelium
3.Increased platelet adhesion
4.Increased blood viscosity
5.Defective fibrinolysis
MICROVASCULAR LEAKAGE
•Microvascular leakage is caused by:
•Impairment of endothelial tight junctions
•Loss of pericytes
•Weakening of capillary walls
•Elevated levels of vascular endothelial growth
factor (VEGF)
PREVENTION
90 percent of diabetic eye disease can be
prevented simply by proper regular
examinations, treatment and by controlling
blood sugar.
•PRIMARY Y PREVENTION
• Strict glycemic control
• Blood pressure control
•SECONDARY PREVENTION
•Annual eye exam
•TERITARY PREVENTION
•Retinal laser photocoagulation
•vitrectomy
CONCLUSION
Diabetic Retinopathy is preventable through
strict glycemic control and annual dilated eye
exams by an ophthalmologist.
Diabetic retinopathy from pathophysiology.pptx

More Related Content

Similar to Diabetic retinopathy from pathophysiology.pptx

Non proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akanaNon proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akanaMohan Phaneendra Akana
 
Biomarkers of diabetic retinopathy
Biomarkers of diabetic retinopathyBiomarkers of diabetic retinopathy
Biomarkers of diabetic retinopathyrx_sonali
 
Diabetes mellitus type II
Diabetes mellitus type II Diabetes mellitus type II
Diabetes mellitus type II Abdul Waris
 
Diabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to ManagementDiabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to ManagementKemi Dele-Ijagbulu
 
Diabetes mellitus type 1 and type 2 by mohammad yaser hussain
Diabetes mellitus type 1 and type 2 by mohammad yaser hussainDiabetes mellitus type 1 and type 2 by mohammad yaser hussain
Diabetes mellitus type 1 and type 2 by mohammad yaser hussainMohammed Yaser Hussain
 
DIABETES AND ITS MANAGEMENT
DIABETES AND ITS MANAGEMENTDIABETES AND ITS MANAGEMENT
DIABETES AND ITS MANAGEMENTDhawal Pal
 
Diabetes Mellitus.ppsx
Diabetes Mellitus.ppsxDiabetes Mellitus.ppsx
Diabetes Mellitus.ppsxAkhilesh bhura
 
DIABETIC RETINOPATHY
DIABETIC RETINOPATHYDIABETIC RETINOPATHY
DIABETIC RETINOPATHYnemat1994
 
Unit 1_Definition & Epidemiology of DM2(1).pptx
Unit 1_Definition & Epidemiology of DM2(1).pptxUnit 1_Definition & Epidemiology of DM2(1).pptx
Unit 1_Definition & Epidemiology of DM2(1).pptxImanuIliyas
 
Diabetic Retinopathy_Dr. Bastola.pptx
Diabetic Retinopathy_Dr. Bastola.pptxDiabetic Retinopathy_Dr. Bastola.pptx
Diabetic Retinopathy_Dr. Bastola.pptxDr. Pradeep Bastola
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitusRikha Decha
 
Diabetic retinopathy group 7 period 2 new 4
Diabetic retinopathy group 7 period 2 new 4Diabetic retinopathy group 7 period 2 new 4
Diabetic retinopathy group 7 period 2 new 4renataoffen
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathyHealthworld4u
 
Current Management of Diabetes Mellitus by Ghaza khan.
Current Management of Diabetes Mellitus by Ghaza khan.Current Management of Diabetes Mellitus by Ghaza khan.
Current Management of Diabetes Mellitus by Ghaza khan.Ghaza Khan
 
Current management of Diabetes Mellitus by Ghaza khan.
Current management of Diabetes Mellitus by Ghaza khan.Current management of Diabetes Mellitus by Ghaza khan.
Current management of Diabetes Mellitus by Ghaza khan.Ghaza Khan
 

Similar to Diabetic retinopathy from pathophysiology.pptx (20)

Non proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akanaNon proliferative diabetic retinopathy by phaneendra akana
Non proliferative diabetic retinopathy by phaneendra akana
 
Biomarkers of diabetic retinopathy
Biomarkers of diabetic retinopathyBiomarkers of diabetic retinopathy
Biomarkers of diabetic retinopathy
 
Diabetes mellitus type II
Diabetes mellitus type II Diabetes mellitus type II
Diabetes mellitus type II
 
Diabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to ManagementDiabetes Mellitus: Approach to Management
Diabetes Mellitus: Approach to Management
 
Diabetes mellitus type 1 and type 2 by mohammad yaser hussain
Diabetes mellitus type 1 and type 2 by mohammad yaser hussainDiabetes mellitus type 1 and type 2 by mohammad yaser hussain
Diabetes mellitus type 1 and type 2 by mohammad yaser hussain
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Diabetes freedom
Diabetes freedomDiabetes freedom
Diabetes freedom
 
DIABETES AND ITS MANAGEMENT
DIABETES AND ITS MANAGEMENTDIABETES AND ITS MANAGEMENT
DIABETES AND ITS MANAGEMENT
 
Diabetes Mellitus.ppsx
Diabetes Mellitus.ppsxDiabetes Mellitus.ppsx
Diabetes Mellitus.ppsx
 
DIABETIC RETINOPATHY
DIABETIC RETINOPATHYDIABETIC RETINOPATHY
DIABETIC RETINOPATHY
 
Unit 1_Definition & Epidemiology of DM2(1).pptx
Unit 1_Definition & Epidemiology of DM2(1).pptxUnit 1_Definition & Epidemiology of DM2(1).pptx
Unit 1_Definition & Epidemiology of DM2(1).pptx
 
Diabetes Mellitus
Diabetes MellitusDiabetes Mellitus
Diabetes Mellitus
 
Diabetic Retinopathy_Dr. Bastola.pptx
Diabetic Retinopathy_Dr. Bastola.pptxDiabetic Retinopathy_Dr. Bastola.pptx
Diabetic Retinopathy_Dr. Bastola.pptx
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
Diabetic retinopathy group 7 period 2 new 4
Diabetic retinopathy group 7 period 2 new 4Diabetic retinopathy group 7 period 2 new 4
Diabetic retinopathy group 7 period 2 new 4
 
Diabetes mellitus
Diabetes mellitusDiabetes mellitus
Diabetes mellitus
 
diabetes
diabetesdiabetes
diabetes
 
Diabetic retinopathy
Diabetic retinopathyDiabetic retinopathy
Diabetic retinopathy
 
Current Management of Diabetes Mellitus by Ghaza khan.
Current Management of Diabetes Mellitus by Ghaza khan.Current Management of Diabetes Mellitus by Ghaza khan.
Current Management of Diabetes Mellitus by Ghaza khan.
 
Current management of Diabetes Mellitus by Ghaza khan.
Current management of Diabetes Mellitus by Ghaza khan.Current management of Diabetes Mellitus by Ghaza khan.
Current management of Diabetes Mellitus by Ghaza khan.
 

More from sathishvsathish1

typhoid fever public health care .pptx
typhoid fever public health care   .pptxtyphoid fever public health care   .pptx
typhoid fever public health care .pptxsathishvsathish1
 
Lecture 12. Antiepileptic drugs pharmacology.pptx
Lecture 12. Antiepileptic drugs pharmacology.pptxLecture 12. Antiepileptic drugs pharmacology.pptx
Lecture 12. Antiepileptic drugs pharmacology.pptxsathishvsathish1
 
protozoans kd sync dud six ch vii goo .pptx
protozoans kd sync dud six ch vii goo .pptxprotozoans kd sync dud six ch vii goo .pptx
protozoans kd sync dud six ch vii goo .pptxsathishvsathish1
 
Pathology_Stom_Eng_2021_(1).pdf
Pathology_Stom_Eng_2021_(1).pdfPathology_Stom_Eng_2021_(1).pdf
Pathology_Stom_Eng_2021_(1).pdfsathishvsathish1
 
internationalredcross-171220093004.pdf
internationalredcross-171220093004.pdfinternationalredcross-171220093004.pdf
internationalredcross-171220093004.pdfsathishvsathish1
 
presentationofstreptococcus-180731145601.pdf
presentationofstreptococcus-180731145601.pdfpresentationofstreptococcus-180731145601.pdf
presentationofstreptococcus-180731145601.pdfsathishvsathish1
 
qualitycontrolinbiochemistry-190731013722.pdf
qualitycontrolinbiochemistry-190731013722.pdfqualitycontrolinbiochemistry-190731013722.pdf
qualitycontrolinbiochemistry-190731013722.pdfsathishvsathish1
 
b-150112001834-conversion-gate02.pptx
b-150112001834-conversion-gate02.pptxb-150112001834-conversion-gate02.pptx
b-150112001834-conversion-gate02.pptxsathishvsathish1
 
streptococcus-160204030310.pdf
streptococcus-160204030310.pdfstreptococcus-160204030310.pdf
streptococcus-160204030310.pdfsathishvsathish1
 

More from sathishvsathish1 (18)

typhoid fever public health care .pptx
typhoid fever public health care   .pptxtyphoid fever public health care   .pptx
typhoid fever public health care .pptx
 
Lecture 12. Antiepileptic drugs pharmacology.pptx
Lecture 12. Antiepileptic drugs pharmacology.pptxLecture 12. Antiepileptic drugs pharmacology.pptx
Lecture 12. Antiepileptic drugs pharmacology.pptx
 
protozoans kd sync dud six ch vii goo .pptx
protozoans kd sync dud six ch vii goo .pptxprotozoans kd sync dud six ch vii goo .pptx
protozoans kd sync dud six ch vii goo .pptx
 
Pathology_Stom_Eng_2021_(1).pdf
Pathology_Stom_Eng_2021_(1).pdfPathology_Stom_Eng_2021_(1).pdf
Pathology_Stom_Eng_2021_(1).pdf
 
lower limb.pdf
 lower limb.pdf lower limb.pdf
lower limb.pdf
 
DEFENCE MECHANISMS.pptx
DEFENCE MECHANISMS.pptxDEFENCE MECHANISMS.pptx
DEFENCE MECHANISMS.pptx
 
TESTIS.pptx
TESTIS.pptxTESTIS.pptx
TESTIS.pptx
 
Blood physiology.pdf
Blood physiology.pdfBlood physiology.pdf
Blood physiology.pdf
 
Health insurance 2.pdf
Health insurance 2.pdfHealth insurance 2.pdf
Health insurance 2.pdf
 
internationalredcross-171220093004.pdf
internationalredcross-171220093004.pdfinternationalredcross-171220093004.pdf
internationalredcross-171220093004.pdf
 
presentationofstreptococcus-180731145601.pdf
presentationofstreptococcus-180731145601.pdfpresentationofstreptococcus-180731145601.pdf
presentationofstreptococcus-180731145601.pdf
 
qualitycontrolinbiochemistry-190731013722.pdf
qualitycontrolinbiochemistry-190731013722.pdfqualitycontrolinbiochemistry-190731013722.pdf
qualitycontrolinbiochemistry-190731013722.pdf
 
b-150112001834-conversion-gate02.pptx
b-150112001834-conversion-gate02.pptxb-150112001834-conversion-gate02.pptx
b-150112001834-conversion-gate02.pptx
 
Human anatomy.pdf
Human anatomy.pdfHuman anatomy.pdf
Human anatomy.pdf
 
09 - Carbon
09 - Carbon09 - Carbon
09 - Carbon
 
04 - Peptides.pptx
04 - Peptides.pptx04 - Peptides.pptx
04 - Peptides.pptx
 
streptococcus-160204030310.pdf
streptococcus-160204030310.pdfstreptococcus-160204030310.pdf
streptococcus-160204030310.pdf
 
07 - Vitamins.ppt
07 - Vitamins.ppt07 - Vitamins.ppt
07 - Vitamins.ppt
 

Recently uploaded

Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...jaredbarbolino94
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfSumit Tiwari
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfMahmoud M. Sallam
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementmkooblal
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Celine George
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitolTechU
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxthorishapillay1
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxRaymartEstabillo3
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxabhijeetpadhi001
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentInMediaRes1
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxAvyJaneVismanos
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 

Recently uploaded (20)

Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...Historical philosophical, theoretical, and legal foundations of special and i...
Historical philosophical, theoretical, and legal foundations of special and i...
 
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdfEnzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
Enzyme, Pharmaceutical Aids, Miscellaneous Last Part of Chapter no 5th.pdf
 
Pharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdfPharmacognosy Flower 3. Compositae 2023.pdf
Pharmacognosy Flower 3. Compositae 2023.pdf
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
Hierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of managementHierarchy of management that covers different levels of management
Hierarchy of management that covers different levels of management
 
Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17Computed Fields and api Depends in the Odoo 17
Computed Fields and api Depends in the Odoo 17
 
ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)ESSENTIAL of (CS/IT/IS) class 06 (database)
ESSENTIAL of (CS/IT/IS) class 06 (database)
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
Capitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptxCapitol Tech U Doctoral Presentation - April 2024.pptx
Capitol Tech U Doctoral Presentation - April 2024.pptx
 
Proudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptxProudly South Africa powerpoint Thorisha.pptx
Proudly South Africa powerpoint Thorisha.pptx
 
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptxEPANDING THE CONTENT OF AN OUTLINE using notes.pptx
EPANDING THE CONTENT OF AN OUTLINE using notes.pptx
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
MICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptxMICROBIOLOGY biochemical test detailed.pptx
MICROBIOLOGY biochemical test detailed.pptx
 
Meghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media ComponentMeghan Sutherland In Media Res Media Component
Meghan Sutherland In Media Res Media Component
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
Final demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptxFinal demo Grade 9 for demo Plan dessert.pptx
Final demo Grade 9 for demo Plan dessert.pptx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 

Diabetic retinopathy from pathophysiology.pptx

  • 2. DIABETES MELLITUS • Diabetes Mellitus is a group of diseases characterized by high blood glucose levels. Diabetes results from defects in the body’s ability to produce and/or use insulin. • Type 1 diabetes is usually diagnosed in children and young adults, and was previously known as juvenile diabetes. In type 1 diabetes, the body does not produce insulin. 5% of people with diabetes have this form of the disease. • In Type 2 diabetes, either the body does not produce enough insulin or the cells ignore the insulin. This is the most common form of diabetes.
  • 3. DIABETIC RETINOPATHY (DR) • Diabetic Retinopathy (DR) Definition: • Progressive dysfunction of the retinal blood vessels caused by chronic hyperglycemia. • DR can be a complication of diabetes type 1 or diabetes type 2. • Initially, DR is asymptomatic, if not treated though it can cause low vision and blindness.
  • 4. RETINA The retina is a multilayered, light sensitive neural tissue lining the inner eye ball. Light is focused onto the retina and then transmitted to the brain through the optic nerve. The macula is a highly sensitive area in the center of the retina, responsible for central vision. The macula is needed for reading, recognizing faces and executing other activities that require fine, sharp vision.
  • 5.
  • 6.
  • 7.
  • 8. DIABETIC RETINOPATHY EPIDEMIOLOGY The total number of people with diabetes is projected to rise from 285 million in 2010 to 439 million in 2030. Diabetic retinopathy is responsible for 1.8 million of the 37 million cases of blindness throughout the world . Diabetic retinopathy (DR) is the leading cause of blindness in people of working age in industrialized countries.
  • 9. SYMPTOMS •It is asymptomatic In early stages •As the disease progresses symptoms may include •Blurred vision •Floaters •Fluctuating vision
  • 10. •Dark areas in the vision •Poor night vision •Impaired color vision •Partial or total loss of vision
  • 11. RISK FACTORS 1.Duration of diabetes 2.Poor Blood Sugar control 3.Hypertension 4.Hyperlipidemia 5.Barriers to care
  • 12. •Duration of diabetes is a major risk factor associated with the development of diabetic retinopathy •The severity of hyperglycemia is the key alterable risk factor associated with the development of diabetic retinopathy
  • 13. PATHOPHYSIOLOGY Diabetic Retinopathy is a microvasculopathy that causes: 1.Retinal capillary occlusion 2.Retinal capillary leakage
  • 14. MICROVASCULAR OCCLUSION •It is caused by 1.Thickening of capillary basement membranes 2.Abnormal proliferation of capillary endothelium 3.Increased platelet adhesion 4.Increased blood viscosity 5.Defective fibrinolysis
  • 15. MICROVASCULAR LEAKAGE •Microvascular leakage is caused by: •Impairment of endothelial tight junctions •Loss of pericytes •Weakening of capillary walls •Elevated levels of vascular endothelial growth factor (VEGF)
  • 16. PREVENTION 90 percent of diabetic eye disease can be prevented simply by proper regular examinations, treatment and by controlling blood sugar.
  • 17. •PRIMARY Y PREVENTION • Strict glycemic control • Blood pressure control •SECONDARY PREVENTION •Annual eye exam •TERITARY PREVENTION •Retinal laser photocoagulation •vitrectomy
  • 18.
  • 19.
  • 20. CONCLUSION Diabetic Retinopathy is preventable through strict glycemic control and annual dilated eye exams by an ophthalmologist.